Full text is available at the source.
Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management
Obstructive Sleep Apnea, High Blood Pressure, and Heart Risks: Causes, Effects, and Treatments
AI simplified
Abstract
Obstructive sleep apnea (OSA) is associated with an elevated risk of hypertension and cardiovascular disease.
- Multiple factors, including neurohormonal changes, impaired blood vessel function, and inflammation, contribute to the relationship between OSA and increased vascular risk.
- Continuous positive airway pressure (CPAP) therapy reduces blood pressure but does not show a reduction in cardiovascular risk on its own.
- Combining CPAP with weight loss may have a synergistic effect on lowering blood pressure and improving various metabolic health markers.
- Poor adherence to CPAP therapy is common, which may diminish the perceived cardiovascular benefits of the treatment.
- Focusing on improving adherence to CPAP and promoting weight loss is important for reducing cardiovascular risk in individuals with OSA.
AI simplified